Loading organizations...
3W Capital functions as a venture capital and private equity firm, providing investment and strategic consulting to early-stage enterprises. The firm specifically targets startups within the information technology sector, supplying capital and expert guidance. Its objective is to accelerate development and market entry for innovative offerings.
Details concerning 3W Capital’s founders and precise inception are not widely publicized. The firm was established with a core belief in innovation’s transformative power, recognizing the need for early-stage support for companies poised to disrupt markets. Its formation addresses demand for strategic investment in pioneering ventures.
The firm primarily serves technology-focused startups seeking financial backing and operational expertise. 3W Capital dedicates itself to fostering technological advancement and contributing to the digital economy. Its long-term vision is to empower new companies to drive change and redefine future industries.
3W Capital has 3 tracked investments across 3 companies. The latest tracked deal is $130.0M Series B in Orange Dental in January 2024.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jan 1, 2024 | Orange Dental | $130.0M Series B | Oceanpine Capital, OrbiMed | Adjuvant Capital, Aihc Capital, Eight Roads Ventures, F Prime Capital, Haitong International, Hillhouse Capital Group, MSA Capital, Superstring Capital |
| Aug 23, 2021 | OPay | $400.0M Series C | Kentaro Matsui | DragonBall Capital, Hongshan Capital Group (Sequoia Capital China), Redpoint China, Softbank Ventures Asia, Source Code Capital |
| Feb 1, 2021 | LakeShore Biopharma | $130.0M Series B | OrbiMed, Dave Chenn | Adjuvant Capital, Aihc Capital, Eight Roads Ventures, Epiphron Capital, F Prime Capital, Haitong International, Hillhouse Capital, MSA Capital, Superstring Capital |
